Adage Capital Partners’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-292,736
Closed -$9.44M 952
2024
Q3
$9.44M Sell
292,736
-243,753
-45% -$7.2M 0.02% 618
2024
Q2
$12.8M Buy
536,489
+170,034
+46% +$4.36M 0.02% 553
2024
Q1
$10.9M Buy
+366,455
New +$11.5M 0.02% 582
2023
Q3
Sell
-246,550
Closed -$11.1M 928
2023
Q2
$11.1M Buy
246,550
+87,510
+55% +$3.34M 0.02% 554
2023
Q1
$5.48M Buy
+159,040
New +$5.16M 0.01% 699
2018
Q3
Sell
-500,000
Closed -$7.45M 755
2018
Q2
$7.45M Buy
500,000
+175,000
+54% +$2.93M 0.02% 607
2018
Q1
$5.57M Buy
+325,000
New +$5.06M 0.01% 636
2017
Q3
Sell
-500,000
Closed -$11.4M 750
2017
Q2
$11.4M Hold
500,000
0.03% 544
2017
Q1
$9.75M Sell
500,000
-150,000
-23% -$2.91M 0.02% 542
2016
Q4
$10.3M Sell
650,000
-100,000
-13% -$1.66M 0.03% 527
2016
Q3
$15.2M Hold
750,000
0.04% 435
2016
Q2
$13.4M Hold
750,000
0.04% 455
2016
Q1
$9.95M Sell
750,000
-553,156
-42% -$8.55M 0.03% 517
2015
Q4
$26.7M Buy
+1,303,156
New +$24.9M 0.07% 311

Other funds holding SGRY

Adage Capital Partners's SGRY Position: Q4 2024 in Review

Adage Capital Partners sold out of Surgery Partners (SGRY) in Q4 2024, closing a stake of 292,736 shares — an estimated $9.44M sold.

Adage Capital Partners first reported a position in SGRY in Q4 2015 and held it in 14 quarters. The position peaked at $26.7M in Q4 2015. 182 funds tracked by Wall St. Rank hold SGRY as of Q4 2024.

  • Adage Capital Partners reported no remaining Surgery Partners position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 292,736 Surgery Partners shares in Q4 2024, an estimated $9.44M.
  • Adage Capital Partners first reported a position in Surgery Partners in Q4 2015 and held it in 14 quarters.
  • Adage Capital Partners's Surgery Partners position peaked at $26.7M in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.